KALLO INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2021-10-18: Form 8-K; Period of report 2021-10-12; Description 3.02 Unregistered Sales of Equity Securities; Details 3.02.
- 2021-09-21: Form 8-K; Period of report 2021-09-16; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders; Details 5.03.
- 2021-03-26: Form 8-K; Period of report 2021-03-23; Description 8.01 Other Events; Details 8.01.
- 2020-12-23: Form 8-K; Period of report 2020-12-18; Description 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2021-10-18 | 8-K | 2021-10-12 | 3.02 Unregistered Sales of Equity Securities | 3.02 On October 7, 2021 our Board of Directors approved the issuance of the following shares of our Common Stock (the “Subject Shares”): (1) 2,532,000,000 Subject Shares to John Cecil; (2) 610,000,000 Subject Shares to Lloyd Chiotti; (3) 1,284,000,000 Subject Shares to Rajni Kassett; (4) 136,000,000 Subject Shares to Samuel R. Baker; (5) 282,000,000 Subject Shares to Samuel Pyo; and 361,000,000 Subject Shares to John Peter Maria Soosai. | kalo-20211012_8k.htm |
| 2021-09-21 | 8-K | 2021-09-16 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 5.07 Submission of Matters to a Vote of Security Holders | 5.03 On September 19, 2021 we were belatedly informed by the office of the Nevada Secretary of State that our amendment to our Articles of Incorporation (“Amendment”) was duly accepted and filed with the Nevada Secretary of State. 5.07 As set forth above, the holders of certain shares of our Series A Preferred Stock and certain shares of our Series B Preferred who collectively hold 79.88% of the Company’s voting rights approved the Amendment to increase our authorized Common Stock and our authorized Preferred Stock while also authorizing and giving our Board of Directors the right to take certain unilateral actions(subject generally to compliance with the Nevada General Corporation Law and the duties imposed on Directors of a Nevada-domiciled corporation) without generally allowing the Company’s common stock holders to have any right to determine or influence such decisions involving the issuance of our Preferred Stock and the rights that may be granted to each series of Preferred Stock. | kalo-20210916_8k.htm |
| 2021-03-26 | 8-K | 2021-03-23 | 8.01 Other Events | 8.01 On March 23, 2021, we received a letter dated March 22, 2021 (the “Letter”) from the Cabinet Secretary for the National Treasury & Planning, the Republic of Kenya (the “Cabinet Secretary”) informing us that the project and agreements that we previously entered into with Techno-Investment Module Ltd., a corporation formerly domiciled in the Republic of Belarus, and now domiciled in the Kingdom of Spain (“TIM”) and the Republic of Kenya, namely, the Project Contract and the Loan Contract (the “Project”) have been put on hold. | kalo-20210325_8k.htm |
| 2020-12-23 | 8-K | 2020-12-18 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On November 19, 2020 we received executed copies of the following contract documents for National Healthcare Projects from the Ministry of Health and the Ministry of Finance of the State of Eritrea (the “Ministries”) as entered into between and among: the Ministries, Techno-Investment Module Limited, a corporation domiciled in the Republic of Belarus with offices in Minsk, Republic of Belarus (“TIM”) and Kallo, Inc. (the “Agreement”). | kalo-20201222_8k.htm |
| 2020-12-21 | 8-K | 2020-12-18 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On November 19, 2020 we received executed copies of the following contract documents for National Healthcare Projects from the Ministry of Health and the Ministry of Finance of the Republic of Mozambique (the “Ministries”) as entered into between and among: the Ministries, Techno-Investment Module Limited, a corporation domiciled in the Republic of Belarus with offices in Minsk, Republic of Belarus (“TIM”) and Kallo, Inc. (the “Agreement”). | kalo-20201221_8k.htm |
| 2020-12-03 | 8-K | 2020-11-30 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On November 30, 2020 we received executed copies of the following contract documents for National Healthcare Projects from the Ministry of Health and the Ministry of Finance of the Federal Democratic Republic of Ethiopia (the “Ministry” or the “Borrower”) as entered into between and among: the Ministries, Techno-Investment Module Limited, a corporation domiciled in the Republic of Belarus with offices in Minsk, Republic of Belarus (“TIM”) and Kallo Inc. (the “Agreement”). | kalo-20201203_8k.htm |
| 2020-11-25 | 8-K | 2020-11-19 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 On November 19, 2020 we received executed copies of the following contract documents for National Healthcare Projects from the Ministry of Health and the Ministry of Finance of the Kingdom of Eswatini (the latter commonly and historically referred to as Swaziland and hereinafter referenced as “Eswatini”) (the “Ministries”) as entered into between and among: the Ministries, Techno-Investment Module Limited, a corporation domiciled in the Republic of Belarus with offices in Minsk, Republic of Belarus (“TIM”) and Kallo, Inc. (the “Agreement”). | kalo-20201124_8k.htm |
| 2020-11-16 | 8-K | 2020-11-12 | 4.01 Changes in Registrant's Certifying Accountant; 7.01 Regulation FD Disclosure | 4.01 On November 12, 2020 we retained the services of BF Borgers, Certified Public Accountants (“B.F. Borgers CPA”) to serve as our principal independent accountant for the fiscal years ended December 31, 2018 and December 31, 2019. 7.01 On November 12, 2020 we retained the services of BF Borgers, Certified Public Accountants (“B.F. Borgers CPA”) to serve as our principal independent accountant for the fiscal years ended December 31, 2018 and December 31, 2019. | kalo-20201116_8k.htm |
| 2020-09-14 | 8-K | 2020-09-08 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 As stated above, we entered into that certain Letter Agreement with Accobiotech on September 8, 2020 (the “Letter Agreement”). | kalo-20200911_8k.htm |
| 2020-08-10 | 8-K | 2020-08-05 | 1.01 Entry into a Material Definitive Agreement; 4.01 Changes in Registrant's Certifying Accountant | 1.01 Entry into a Material Definitive Contract. 4.01 On July 20, 2020 the Company completed telephone discussions with BF Borgers, Certified Public Accountants wherein the parties orally agreed that the Company would retain the services of BF Borgers, Certified Public Accountants to serve as the Company’s independent accountant in connection with the Company’s financial statements for the fiscal years following the Company’s fiscal years ending after December 31, 2017. | kalo-20200805_8k.htm |
| 2020-07-30 | 8-K | 2020-07-29 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 7.01 As stated above, we entered into that certain Joint Venture Corporation Agreement (the “Agreement”) with Techno-Investment Module, Ltd, a corporation domiciled in the Republic of Belarus (“TIM”) and Vintage Ventures Limited, a company domiciled in the Republic of Ghana (“Vintage”). | kalo-8k-07232020.htm |
| 2019-12-17 | 8-K | 2019-12-06 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | kalo-8k-12-06-2019.htm |
| 2019-05-10 | 8-K | 2019-05-07 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On May 7 2019, we received the resignation of our principal independent accountant, Malone Bailey, LLP. | kalo-8k-05-07-2019.htm |
| 2019-02-22 | 8-K | 2019-02-22 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant | 1.01 Entry into a Material Definitive Agreement. 3.02 On February 19, 2019 the Company's Board of Directors approved the designation of five million (5,000,000) shares of the Company's Preferred Stock (par value $0.00001) as Series B Preferred Stock (the "Series B Shares") and the issuance of all of the Series B Shares to John Cecil, the Company's President and Chief Executive Officer pursuant to which the Company and John Cecil entered into that certain Investment Agreement of the same date (the "Agreement"). 3.03 On February 19, 2019 the Company's Board of Directors approved the designation of five million (5,000,000) shares of the Company's Preferred Stock (par value $0.00001) as Series B Preferred Stock (the "Series B Shares") and the issuance of all of the Series B Shares to John Cecil, the Company's President and Chief Executive Officer pursuant to which the Company and John Cecil entered into that certain Investment Agreement of the same date (the "Agreement"). 5.01 On February 19, 2019 the Company's Board of Directors approved the designation of five million (5,000,000) shares of the Company's Preferred Stock (par value $0.00001) as Series B Preferred Stock (the "Series B Shares") and the issuance of all of the Series B Shares to John Cecil, the Company's President and Chief Executive Officer pursuant to which the Company and John Cecil entered into that certain Investment Agreement of the same date (the "Agreement"). | kalo8k-02222018.htm |
| 2018-09-27 | 8-K | 2018-09-26 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | kalo-8k-0926-2018.htm |
| 2018-04-18 | 8-K | 2018-04-18 | 7.01 Regulation FD Disclosure | 7.01 Based on our current assessments of market interest, we believe that our Kallo Integrated Delivery System ("KIDS") continues to receive strong interest as a "Healthcare Delivery Solution" in certain developing countries. | kalo8k-04182018.htm |
| 2017-04-18 | 8-K | 2017-04-08 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On April 8, 2017, we entered into an agreement with FE Pharmacy Inc., an Ontario corporation wherein in consideration of the issuance by us of 475,000,000 post reverse-split restricted shares of our common stock to FE Pharmacy, FE Pharmacy will pay all of our outstanding indebtedness as of April 7, 2017. 3.02 On April 8, 2017, we entered into an agreement with FE Pharmacy Inc., an Ontario corporation wherein in consideration of the issuance by us of 475,000,000 post reverse-split restricted shares of our common stock to FE Pharmacy, FE Pharmacy will pay all of our outstanding indebtedness as of April 7, 2017. | kalo8k-04172017.htm |
| 2016-02-29 | 8-K | 2016-02-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 29, 2016, Vince Leitao resigned as our president and chief operating officer. | kalo8k-02292016.htm |
| 2015-12-08 | 8-K | 2015-12-08 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On November 19, 2015, Vince Leitao resigned as our director. | kalo8k-12082015.htm |
| 2015-12-02 | 8-K | 2015-12-01 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On November 23, 2015, we filed amended articles of incorporation with the Secretary of State of Nevada to increase our authorized shares of common stock to 15,000,000,000 shares. | kalo8k-12012015.htm |
| 2015-06-24 | 8-K | 2015-06-23 | 7.01 Regulation FD Disclosure | 7.01 On June 23, 2015, we announced the Minister of Health and Public Hygiene, Hon. | kalo8k-06232015.htm |
| 2015-06-08 | 8-K | 2015-06-05 | 7.01 Regulation FD Disclosure | 7.01 On June 8, 2015, we announced that Mr. Cecil recently visited Guinea at the invitation of His Excellency, President Alpha Conde, to refine delivery schedules for the current MobileCare Supply contract and expand Kallo's on-going role as a key strategic partner to support Guinea in continued expansion of its healthcare delivery infrastructure. | kalo8k-06052015.htm |
| 2015-03-10 | 8-K | 2015-03-10 | 7.01 Regulation FD Disclosure | 7.01 On February 20, 2015, His Excellency, Alpha Conde, President of the Republic of Guinea and, on behalf of the government, extends his deepest sympathy to the families who have lost a loved one during the Ebola outbreak. | kalo8k-03102015.htm |
| 2015-03-03 | 8-K | 2015-03-02 | 3.02 Unregistered Sales of Equity Securities | 3.02 The foregoing Series A Preferred shares were issued in consideration of $950.00. | kalo8k-03022015.htm |
| 2015-01-27 | 8-K | 2015-01-27 | 7.01 Regulation FD Disclosure | 7.01 On January 27, 2015, we announced that the office of the Minister of Finance – Ghana has been presented an offer to finance healthcare projects in Ghana valued at Euros 850 million. | kalo8k-01272015.htm |
| 2014-11-21 | 8-K | 2014-11-20 | 7.01 Regulation FD Disclosure | 7.01 On November 20, 2014, we announced Dr. Marion Lyver is joining Kallo Inc as Chief Medical Officer effective December 01, 2014. | kalo8k11202014.htm |
| 2014-11-13 | 8-K/A | 2014-11-12 | 7.01 Regulation FD Disclosure | 7.01 On November 13, 2014, we are announcing the Minister of Finance – Ghana has officially invited us to Ghana for final discussions on financing so as to move forward with our MobileCare, RurulCare and National Dialysis Program." Says Mr. John Cecil, our Chairman and CEO. | kalo8ka1-11122014.htm |
| 2014-11-13 | 8-K | 2014-11-12 | 7.01 Regulation FD Disclosure | 7.01 On November 13, 2014, we are announcing the Minister of Finance – Ghana has officially invited us to Ghana for final discussions on financing so as to move forward without MobileCare, RurulCare and National Dialysis Program." Says Mr. John Cecil, our Chairman and CEO. | kalo8k-11122014.htm |
| 2014-11-05 | 8-K | 2014-11-05 | 7.01 Regulation FD Disclosure | 7.01 On November 5, 2014, further to our business development update provided earlier this week, our chairman and CEO, Mr. John Cecil is delighted to announce that the Minister of Health of Ghana, Hon. | kalo8k-11052014.htm |
| 2014-10-31 | 8-K | 2014-10-31 | 7.01 Regulation FD Disclosure | 7.01 On November 3, 2014, we will announce that in January, we signed a $200 million dollar supply contract for our MobileCare TM Program with the Republic of Guinea. | kalo8k-10312014.htm |
| 2014-08-13 | 8-K/A | 2014-08-12 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On June 3, 2014, we terminated Schwartz Levitsky Feldman LLP, 2300 Yonge Street, Suite 1500, Toronto, Ontario, Canada M4P 1E4 as our independent registered accounting firm. | kalo8ka3-08122014.htm |
| 2014-08-08 | 8-K/A | 2014-06-03 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On June 3, 2014, we terminated Schwartz Levitsky Feldman LLP, 2300 Yonge Street, Suite 1500, Toronto, Ontario, Canada M4P 1E4 as our independent registered accounting firm. | kalo8ka2-08082014.htm |
| 2014-07-08 | 8-K | 2014-07-08 | 7.01 Regulation FD Disclosure | 7.01 In January 2014, we revealed plans for a new head office and be fully operational in the third quarter of 2014. | kalo8k-07082014.htm |
| 2014-06-13 | 8-K | 2014-06-13 | 7.01 Regulation FD Disclosure | 7.01 On June 13, 2014, we announced that the Ministry of Health and Sanitation of the Republic of Sierra Leone through Permanent Secretary Mr. Sadiq Kapuwa has conveyed the Ministry's interest in our proposal and extended an invitation to us to visit Sierra Leone between August and September 2014 to meet with senior technical officials of the Ministry to further discuss our proposal and enhance management decision to move forward with the Kallo MobileCare initiative. | kalo8k-06132014.htm |
| 2014-06-13 | 8-K/A | 2014-06-13 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On June 3, 2014, we terminated Schwartz Levitsky Feldman LLP, 2300 Yonge Street, Suite 1500, Toronto, Ontario, Canada M4P 1E4 as our independent registered accounting firm. | kalo8ka1-6132014.htm |
| 2014-06-05 | 8-K | 2014-06-05 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On June 3, 2014, we terminated Schwartz Levitsky Feldman LLP, 2300 Yonge Street, Suite 1500, Toronto, Ontario, Canada M4P 1E4 as our independent registered accounting firm. | kalo8k-06052014.htm |
| 2014-03-24 | 8-K | 2014-03-21 | 7.01 Regulation FD Disclosure | 7.01 On March 13, 2014, a press report, approved by the Press Secretary to the Government of Guinea, announced Kallo’s MobileCareTM & RuralCareTM for the Republic of Guinea is a holistic solution addressing healthcare delivery and optimizes the scope and efficiency of care by delivering higher standards through technology. | kalo8k-3212014.htm |
| 2014-02-10 | 8-K | 2013-04-30 | 7.01 Regulation FD Disclosure | 7.01 Today we announced that Dell will design and build the IT infrastructure for our healthcare delivery platform. | kalo8k-2102014.htm |
| 2014-01-31 | 8-K | 2014-01-31 | 7.01 Regulation FD Disclosure | 7.01 In light of the recent US $200 million supply contract signed with the Republic of Guinea, today, we announced that we are gearing up to establish a state-of-the-art new global head office in Markham, Ontario. | kalo8k-1312014.htm |
| 2014-01-23 | 8-K | 2014-01-22 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 Kallo Inc. has signed a Supply Contract worth $200,000,925.00 US (Two Hundred million nine hundred and twenty-five US dollars) for the supply and maintenance of Kallo MobileCare and RuralCare with the Ministry of Health and Public Hygiene of the Government of the Republic of Guinea. 7.01 We announced the signing of a US$200,000,925.00 (Two Hundred million nine hundred and twenty-five US dollars) Supply Contract with the Ministry of Health and Public Hygiene of the Republic Of Guinea. | kalo8k-1222014.htm |
| 2013-12-06 | 8-K | 2013-12-06 | 7.01 Regulation FD Disclosure | 7.01 On December 6, 2013, we issued a press release announcing that the Minister of Health and Public Hygiene, his Excellency Doctor Edouard Niankoye Lama, announced today that Guinea will implement a unique healthcare delivery program to bring a high standard of healthcare to its rural population and accelerate the progress towards Guinea’s healthcare Millennium Development Goals. | kalo8k-12062013.htm |
| 2013-11-12 | 8-K | 2013-11-08 | 7.01 Regulation FD Disclosure | 7.01 On November 7, 2013, we issued a press release announcing that Monsieur Directeur Général de l’Administration et Controle des Grands Project (ACGP) Guinea has officially confirmed final discussions with the Company on financing, contracts and delivery timelines of Kallo MobileCare™. | kalo8k-11082013.htm |
| 2013-10-08 | 8-K | 2013-10-07 | 7.01 Regulation FD Disclosure | 7.01 We released the attached information pertaining to update communications with the Nation of Guinea. | kalo8k-10072013.htm |
| 2013-08-02 | 8-K | 2013-08-01 | 7.01 Regulation FD Disclosure | 7.01 We released the attached information pertaining to John Cecil’s communications with the Nation of Ghana. | kalo8k-8012013.htm |
| 2013-07-18 | 8-K | 2013-07-18 | 3.02 Unregistered Sales of Equity Securities | 3.02 On September 26, 2012, we entered into an agreement for the resale of up to 50,000,000 shares of common stock issuable to Kodiak Capital Group, LLC (“Kodiak”) pursuant to an Investment Agreement (the “Investment Agreement” or “Equity Line of Credit”). | kalo8k-7182013.htm |
| 2012-11-16 | 8-K | 2012-11-16 | 7.01 Regulation FD Disclosure | 7.01 On November 16, 2012, we will announce at the recently held Practical Pediatrics Ontario Conference on November 9th and 10th, we introduced EMCURx PEMR, an electronic medical record system that was specially customized for pediatric practices and work flows, and recommended by the Pediatrics Section, Ontario Medical Association (OMA) as the EMR of choice that Ontario Pediatricians should strongly consider for their practices. | kalo8k-11162012.htm |
| 2012-10-02 | 8-K | 2012-10-02 | 7.01 Regulation FD Disclosure | 7.01 On October 1, 2012, we announced that we have entered into a $2 million common stock purchase agreement with Kodiak Capital Group, LLC, a Newport Beach-based institutional investor subject to our performance of certain conditions. | kalo8k-10022012.htm |
| 2012-09-24 | 8-K | 2012-09-24 | 3.02 Unregistered Sales of Equity Securities | 3.02 Between May 5, 2012 and September 7, 2012, we issued 12,815,113 restricted shares of common stock to 3 persons in consideration of $640,755.67. | kalo8k-9242012.htm |
| 2012-08-20 | 8-K | 2012-08-20 | 7.01 Regulation FD Disclosure | 7.01 We are excited to announce the acceptance of a purchase order for EMCURx, the only Electronic Medical Record System (EMR) designed for Clinical Specialists in Canada. | kalo8k-8202012.htm |
| 2012-07-11 | 8-K | 2012-07-10 | 7.01 Regulation FD Disclosure | 7.01 We are excited to announce that the Government of Ghana has extended an invitation to Kallo to visit Accra, Ghana on the 23rd of July for final discussions for approval of distribution and operation of Kallo’s Mobile Care Clinics. | kalo8k-7102012.htm |
| 2012-06-29 | 8-K | 2012-06-28 | 7.01 Regulation FD Disclosure | 7.01 We are pleased to announce we are currently licensed to distribute our Electronic Medical Record (EMR) systems, Picture Archiving and Communication System (PACS), and Medical Device Connectivity System (MDC) throughout the United States and Canada. | kalo8k-6282012.htm |
| 2012-06-28 | 8-K | 2012-06-27 | 7.01 Regulation FD Disclosure | 7.01 With a strategic vision to provide leading edge technologies and solutions at better prices, we have globally launched three of our seven technologies in the last three quarters. | kalo8k-622012.htm |
| 2012-06-01 | 8-K | 2012-06-01 | 7.01 Regulation FD Disclosure | 7.01 With a strategic vision to provide leading edge technologies and solutions at better prices, we announced today the launch of a price disruptive PACS/RIS system. | kalo8k-6012012.htm |
| 2012-03-05 | 8-K | 2012-03-05 | 3.02 Unregistered Sales of Equity Securities | 3.02 On February 29, 2012, our board of directors approved the issuance of 23,016,963 unregistered shares of common stock to 15 individuals in consideration of $1,150,848.15. | ki8k-3052012.htm |
| 2012-02-15 | 8-K/A | 2012-02-10 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On February 6, 2012, Collins Barrow Toronto LLP, Collins Barrow Place, 11 King Street West, Suite 700, Box 27, Toronto, Ontario, Canada M5H 4C7 terminated its relationship with us as our auditor (See “Exhibit 16.3” attached hereto). | ki8ka1-2142012.htm |
| 2012-02-10 | 8-K | 2012-02-06 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On February 6, 2012, Collins Barrow Toronto LLP, Collins Barrow Place, 11 King Street West, Suite 700, Box 27, Toronto, Ontario, Canada M5H 4C7 terminated its relationship with us as our auditor. | ki8k-2092012.htm |
| 2012-02-02 | 8-K | 2012-02-01 | 3.02 Unregistered Sales of Equity Securities | ki8k-2022012.htm | |
| 2012-01-26 | 8-K | 2012-01-26 | 1.01 Entry into a Material Definitive Agreement | 1.01 On January 13, 2012 we entered into an Independent Contractor Agreement (the “Agreement”) with Savers Drug Mart (“Savers”) wherein Savers agreed to provide the following services to us: pharmacy management; pharmacy technician training; dispensary formulary planning; pharmaceutical procurement; and pricing strategies. | ki8k-1262012.htm |
| 2011-11-07 | 8-K | 2011-11-07 | 7.01 Regulation FD Disclosure | 7.01 On November 7, 2011, to enhance our ability to address a global need for the provision of healthcare services in remote areas, we have signed a formal agreement with PetroData Management Services Limited. | ki8k-11072011.htm |
| 2011-11-03 | 8-K | 2011-11-02 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 24, 2011, we entered into a Strategic Alliance Agreement (the “Agreement”)with Petro data Management Services Limited (“PDMS”) and Gateway Global Fabrication Ltd. (“Gateway”) wherein we retained PDMS and Gateway (collectively “Agents”) as our agents to market our Mobile Medical Clinics in Nigeria. | ki8k-11022011.htm |
| 2011-11-02 | 8-K | 2011-11-02 | 7.01 Regulation FD Disclosure | 7.01 On November 1, 2011, we announced the launch of our mobile medical clinic “Mobile Care™” – a mobile medical care unit that comes as the result of more than 18 months of diligent product and technology infrastructure development. | ki8k-11022011.htm |
| 2011-10-28 | 8-K | 2011-10-28 | 1.01 Entry into a Material Definitive Agreement | 1.01 On October 24, 2011, we entered into a Multimedia Contractual Agreement (the “Agreement”) with David Miller wherein we retained Mr. Miller to provide consulting services to us relating to marketing our business and products to the public. | ki8k-10282011.htm |
| 2011-09-28 | 8-K | 2011-09-28 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 5.07 Submission of Matters to a Vote of Security Holders | 1.01 On September 21, 2011, we entered into an agreement with Herb Adams wherein we amended our agreement dated January 12, 2011 with Mr. Adams and agreed to issue Mr. Adams 533,334 shares of common stock from our incentive stock option plan registered on Form S-8 for services previously rendered to us valued at $40,000.00. 3.02 On September 22, 2011, we issued 13,604,132 restricted shares of common stock to 15 creditors of Kallo Inc. in consideration of satisfaction of $680,207 in outstanding debt. | ki8k-9282011.htm |
| 2011-06-28 | 8-K | 2011-06-27 | 1.01 Entry into a Material Definitive Agreement | 1.01 On November 8, 2010, we entered into an agreement with Jarr Capital Corp. wherein we engaged Jarr Capital Corp. to provide certain professional services to us in consideration of the payment of cash of $25,000 plus shares of our common stock valued at $40,000. | ki8k-6272011.htm |
| 2011-06-02 | 8-K | 2011-06-02 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On Friday, May 27, 2011, at 11:00 a.m., Eastern Time, at 15 Allstate Parkway, Suite 600, Markham, Ontario, Canada L3R 5B4, we held a special meeting of shareholders to vote on a resolution to amend our Articles of Incorporation to increase the number of authorized shares of Common Stock from one hundred million (100,000,000) shares to five hundred million (500,000,000) shares, par value $0.00001 per share. | ki8k-6022011.htm |
| 2011-04-13 | 8-K | 2011-04-12 | 5.06 Change in Shell Company Status | 5.06 On or about December 31, 2009, as a result of our acquisition of Kallo Technologies Inc. (formerly known as Rophe Medical Technologies Inc.) (“Rophe”) we were no longer were a “shell company” as that term is defined in Rule 405 of the Securities Act of 1933, as amended. | ki8k04122011.htm |
| 2011-03-30 | 8-K | 2011-03-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On March 25, 2011, at a special meeting of the board of directors we removed Leonard Steinmetz as our treasurer, principal financial officer, and principal accounting. | ki8k-3282011.htm |
| 2011-03-02 | 8-K | 2011-02-28 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On February 28, 2011, we terminated, MaloneBailey, LLP, 10350 Richmond Avenue, Suite 800, Houston, Texas 77042 as our independent registered public accounting firm. | ki8k-2282011.htm |
| 2011-02-22 | 8-K | 2011-02-18 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement | 1.01 On February 17, 2011, we amended the agreement we entered into with Jarr Capital Corp. (as reported in our Form 8-K filed with the SEC on November 17, 2010) to increase the offering up to US$5,000,000 at a price of $0.15 per unit. 1.02 On November 10, 2010, we, John Cecil, Vince Leitao, and Samuel Baker, mutually terminated Messrs. | ki8k-2182011.htm |
| 2011-01-21 | 8-K | 2011-01-20 | 3.02 Unregistered Sales of Equity Securities; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 3.02 On January 14, 2011 we issued 4,000,000 restricted shares of common stock to John Cecil, our CEO and a member of the Board of Directors in consideration of the sum of $400.00. 5.03 On January 14, 2011, we changed our name from Diamond Technologies Inc. to Kallo Inc. We accomplished this by creating a wholly owned subsidiary corporation by the name of Kallo Inc., a Nevada corporation and merging it into Diamond Technologies Inc. Diamond Technologies Inc. was the surviving entity. | ki8k-1202011.htm |
| 2010-12-28 | 8-K | 2010-12-27 | 1.02 Termination of a Material Definitive Agreement | 1.02 On December 22, 2010, we terminated our Consulting Services Agreement dated April 22, 2010 and an amendment thereto dated October 5, 2010, with Ten Associates LLC. | dti8k-12272010.htm |
| 2010-12-16 | 8-K | 2010-12-16 | 1.01 Entry into a Material Definitive Agreement | 1.01 On December 10, 2010, we entered into a North American Authorized Agency Agreement (the “Agreement”) with Advanced Software Technologies, Inc., located in the Grand Cayman Islands (“AST”). | dti8k-12162010.htm |
| 2010-11-24 | 8-K | 2010-11-22 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets | 1.01 On October 13, 2010, we entered into a Services Agreement with Buchanan Associates Computer Consulting Ltd. d/b/a Buchanan Associates, a corporation incorporated under the laws of the Province of Ontario (“Buchanan”) pursuant to which Buchanan will provide us with certain computer related services in consideration of the payment of $10,000 plus monthly a monthly fee for hardware, software and managed services of $9,205. 2.01 On October 13, 2010, we entered into a Services Agreement with Buchanan Associates Computer Consulting Ltd. d/b/a Buchanan Associates, a corporation incorporated under the laws of the Province of Ontario (“Buchanan”) pursuant to which Buchanan will provide us with certain computer related services in consideration of the payment of $10,000 plus monthly a monthly fee for hardware, software and managed services of $9,205. | dti8k-11222010.htm |
| 2010-11-19 | 8-K | 2010-11-19 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 On November 15, 2010, we entered into an agreement with Herb Adams to settle claims by Mr. Adams for certain amounts of money. 1.02 On November 17, 2010, by agreement, we terminated our employment agreement with Mary Kricfalusi that we entered into as of April 15, 2010. 2.01 On November 15, 2010, we entered into an agreement with Herb Adams to settle claims by Mr. Adams for certain amounts of money. 5.02 On November 17, 2010, Mary Kricfalusi resigned as secretary and a director of the Company. | dti8k111910.htm |
| 2010-11-17 | 8-K | 2010-11-16 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement | 1.01 On November 8, 2010, we entered into an agreement with Jarr Capital Corp. wherein we engaged Jarr Capital Corp. to provide certain professional services to us in consideration of the payment of cash of $25,000 plus shares of our common stock valued at $40,000. 1.02 On November 8, 2010 we gave notice to Kodiak Capital Group, LLC. that we were terminating the Investment Agreement we entered into with Kodiak Capital Group, LLC. on May 19, 2010 which was reported in our Form S-1 registration statement filed with the SEC on May 25, 2010. | dti8k-11162010.htm |
| 2010-11-05 | 8-K | 2010-11-05 | 3.02 Unregistered Sales of Equity Securities | 3.02 On October 25, 2010 we completed the sale of 1,480,000 Units to five persons at a purchase price of $0.25 per Unit for a total of $370,000.00. | dti8k-11052010.htm |
| 2010-11-03 | 8-K | 2010-11-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 20, 2010, our board of directors appointed John Cecil as Chairman of the Board of Directors and our Chief Executive Officer. | dti8k-11032010.htm |
| 2010-10-14 | 8-K | 2010-10-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 On September 28, 2010, we entered into a lease with RCN Management LP, 15 Allstate Parkway, Suite 600, Markham, Ontario, Canada L3R 5B4 to lease office space at 15 Allstate Parkway, Suite 600, Markham, Ontario, Canada L3R 5B4. | dti8k-10132010.htm |
| 2010-08-27 | 8-K | 2010-08-27 | 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant | 3.02 On August 25, 2010 we sold 2,000,000 shares of common stock to Mary Kricfalusi, one of our officers and directors in consideration of $200.00. 5.01 On August 25, 2010 we sold 2,000,000 shares of common stock to Mary Kricfalusi, one of our officers and directors in consideration of $200.00. | dti8k082710.htm |
| 2010-06-01 | 8-K | 2010-06-01 | 7.01 Regulation FD Disclosure | 7.01 We announced today the appointment of Ten Associates LLC as our exclusive investor relations representative. | dti8k060110.htm |
| 2010-01-07 | 8-K | 2009-12-11 | 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 2.01 On December 31, 2009, we acquired 300 shares of common stock of Rophe Medical Technologies Inc. (Rophe”) which constitute all of the issued and outstanding shares of Rophe common stock in exchange for 3,000,000 restricted shares of our common stock. 3.02 in exchange for 300 shares of common stock of Rophe which constitute all of the issued and outstanding shares of Rophe common stock. 5.01 With 16,870,002 shares of common stock outstanding, the following table sets forth the total number of shares, directly and indirectly, owned by each of our directors, officers and key employees, individually and as a group, and the present owners of 5% or more of our total outstanding shares immediately prior to the share issuance described in Item 3.02 above. 5.02 On December 31, 2009, Vinod Gandhi resigned as our treasurer, principal financial officer, principal accounting officer and as a member of the board of directors. 8.01 On December 16, 2009, we reported that on December 11, 2009, we entered into an agreement with Rophe Medical Technologies Inc. and its shareholders (collectively “Rophe”) wherein we acquired all of the issued and outstanding shares of common stock of Rophe in exchange for: 3,000,000 restricted shares of our common stock and $1,200,000 payable as follows: $50,000 on January 30, 2010; $200,000 on March 31, 2010; $250,000 on April 30, 2010; $233,333 on launch of Project 1; $233,333 on launch of Project 2; and, $233,333 on launch of Project 3. | dti8k121109.htm |
| 2009-12-16 | 8-K | 2009-12-11 | 1.01 Entry into a Material Definitive Agreement | 1.01 On December 11, 2009, we entered into an agreement with Rophe Medical Technologies Inc. and its shareholders (collectively “Rophe”) wherein we acquired all of the issued and outstanding shares of common stock of Rophe in exchange for: 3,000,000 restricted shares of our common stock and $1,200,000 payable as follows: $50,000 within 30 days of the date of the agreement; $200,000 on March 31, 2010; $250,000 on April 30, 2010; $233,333 on launch of Project 1; $233,333 on launch of Project 2; and, $233,333 on launch of Project 3. | dti8k121109.htm |
| 2009-12-03 | 8-K | 2009-11-30 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.03 On November 30, 2009, at a special meeting of shareholders, a majority of outstanding common stock voted to change our name from Printing Components Inc. to Diamond Technologies Inc. On December 1, 2009, we filed amended articles of incorporation with the Nevada Secretary of State reflecting the change of our name. 8.01 In Item 8.01 of our Form 8-K dated May 8, 2008 and filed with the SEC on May 13, 2008, we stated that the public should not rely on any information disseminated by anyone regarding us unless the information appeared in reports filed by us with the United States Securities and Exchange Commission. | dti8k113009.htm |
| 2009-10-28 | 8-K | 2009-10-27 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On October 27, 2009, Herb Adams resigned as an officer and director of Printing Components, Inc. Mr. Adams did not have any disagreements with us on any matter relating to our operations, policies, or practices. | pci8k102709.htm |
| 2009-10-27 | 8-K | 2009-10-21 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On October 21, 2009, we terminated Kempisty & Company, Certified Public Accountants, P.C. at 15 Maiden Lane, Suite 1003, New York, New York 10038, as our independent registered public accounting firm. | pci8k102109.htm |
| 2009-08-21 | 8-K | 2009-08-20 | 8.01 Other Events | 8.01 We have been advised by LyfeTec, Inc. that it will not be proceeding with the reverse acquisition described in our Form 8-K filed with the SEC on July 16, 2009. | pci8k082009.htm |
| 2009-07-16 | 8-K | 2009-07-15 | 7.01 Regulation FD Disclosure | 7.01 Today, we announced we have signed a non-binding letter of intent with LyfeTec, Inc. to acquire LyfeTec, Inc. LyfeTec is a remanufacturing company which resells home medical test screening kit products. | pci8k071609.htm |
| 2008-08-18 | 8-K | 2008-08-12 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | pci8k08162008.htm | |
| 2008-07-14 | 8-K | 2008-07-11 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | pci8k07112008.htm | |
| 2008-05-30 | 8-K | 2008-05-29 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | pci8k05292008.htm | |
| 2008-05-13 | 8-K | 2008-05-08 | 8.01 Other Events | pci8k05082008.htm | |
| 2008-04-09 | 8-K | 2008-04-04 | 1.02 Termination of a Material Definitive Agreement | pci8k04082008.htm | |
| 2008-01-03 | 8-K | 2007-12-28 | 3.02 Unregistered Sales of Equity Securities | pci8k010308.htm | |
| 2007-11-30 | 8-K | 2007-11-26 | 1.01 Entry into a Material Definitive Agreement | pci8k112607.htm |